e-learning
resources
Stockholm 2007
Sunday 16.09.2007
Pleural techniques and diagnosis of peripheral lung nodules
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Intrapleural interleukin 2 in the treatment of persistent pneumothorax in patients not eligible for surgery
P. Cremaschi, L. Conti, C. Catanese, G. Terzuolo, E. Gatto (Pavia, Mortara (Pv), Italy)
Source:
Annual Congress 2007 - Pleural techniques and diagnosis of peripheral lung nodules
Session:
Pleural techniques and diagnosis of peripheral lung nodules
Session type:
Thematic Poster Session
Number:
748
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Cremaschi, L. Conti, C. Catanese, G. Terzuolo, E. Gatto (Pavia, Mortara (Pv), Italy). Intrapleural interleukin 2 in the treatment of persistent pneumothorax in patients not eligible for surgery. Eur Respir J 2007; 30: Suppl. 51, 748
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Role of surgery in pneumothorax treatment
Source: Virtual Congress 2020 – Pneumothorax: to drain or not to drain
Year: 2020
Intrapleural instillation of fibrinolytics in the treatment complicated pneumonia in children. Case study
Source: Eur Respir J 2002; 20: Suppl. 38, 591s
Year: 2002
Intrapleural fibrinolytic treatment with streptokinase for empyema during pregnancy: 2 cases
Source: Annual Congress 2010 - Infections and pleural problems
Year: 2010
Reasons for not receiving interventional therapy in patients with severe emphysema
Source: International Congress 2018 – Endoscopic lung volume reduction
Year: 2018
Thoracoscopic surgery for recurrent pneumothorax of LAM (lymphangioleiomyomatosis) patients needing lung transplantation in the future
Source: Eur Respir J 2005; 26: Suppl. 49, 636s
Year: 2005
The evaluation of 239 patients with bronchiectasis who had surgical therapy
Source: Annual Congress 2006 - Surgery for chronic benign disease and management of complications
Year: 2006
Indications and results of surgical pleurodesis for spontaneous pneumothorax
Source: Annual Congress 2007 - PG16 - Management of pleural problems in your practice today
Year: 2007
Treatment successes with talc pleurodesis at patients (pts.) with recurrent malignant pleural effusions (PE)
Source: Eur Respir J 2002; 20: Suppl. 38, 438s
Year: 2002
Analysis of early postoperative complications in patients underwent pneumonectomy for unilateral destructive pulmonary tuberculosis
Source: International Congress 2019 – General thoracic surgery
Year: 2019
20 years of experience with the surgical treatment of pleural empyema
Source: Eur Respir J 2005; 26: Suppl. 49, 170s
Year: 2005
The evaluation of 287 patients with bronchiectasis who had surgical therapy
Source: Annual Congress 2010 - Infections and pleural problems
Year: 2010
Should oral anticoagulation be discontinued after 3 months in the setting of a first high-risk pulmonary embolism secondary to a major transient/reversible risk factor?
Source: Eur Respir J, 55 (1) 1902028; 10.1183/13993003.02028-2019
Year: 2020
Should oral anticoagulation be discontinued after 3 months in the setting of a first high-risk pulmonary embolism secondary to a major transient/reversible risk factor?
Source: Eur Respir J, 55 (1) 1902323; 10.1183/13993003.02323-2019
Year: 2020
Spontaneous pneumothorax and tuberculosis: long-term follow-up
Source: Eur Respir J 2011; 37: 126-131
Year: 2011
25 years of experience of the surgical treatment of pleural empyema
Source: Annual Congress 2008 - Pleuropulmonary infections; thoracic trauma
Year: 2008
Radiotherapy: a novel treatment for pneumothorax
Source: Eur Respir J 2006; 27: 427-429
Year: 2006
Survival after endoscopic valve therapy in patients with severe emphysema
Source: International Congress 2016 – Endoscopic lung volume reduction I
Year: 2016
Optimizing treatment for life-threatening hemoptysis: a prospective follow-up of 101 patients over 1 year
Source: Eur Respir J 2007; 30: Suppl. 51, 559s
Year: 2007
Iterative therapeutic thoracocentesis as the first-line treatment of complicated parapneumonic effusion: An observational study of 79 consecutive cases
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013
Predictors of clinical outcome in emphysema patients with atelectasis following endoscopic valve therapy
Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept